Gothamist

A non-profit newsroom, powered by WNYC.

Gothamist

WNYC Listen Live

Donate

 

 

News

Biden admin moves to keep abortion pill available while DOJ appeals Texas ban


By

Caroline Lewis

Published Apr 10, 2023


Share

FacebookTwitterRedditEmail


Never miss a story

 Email address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .

U.S. Attorney General Merrick Garland and Deputy Attorney General Lisa Monaco, Jan. 27, 2023

 

Olivier Douliery/AFP via Getty Images


By

Caroline Lewis

Published Apr 10, 2023


Share

FacebookTwitterRedditEmail


We rely on your support to make local news available to all

Make your contribution now and help Gothamist thrive in 2026. Donate today

Gothamist is funded by sponsors and member donations

A Texas ruling on Friday suspending federal approval for the abortion medication mifepristone has set off a flurry of legal activity, leaving the pill’s fate uncertain. The Biden administration is seeking to keep the pill available while it appeals the decision. It is also looking for clarification on a separate ruling out of Washington state that aimed to cancel out the Texas decision.

Here’s how things have unfolded so far:

On Friday, Northern District of Texas Judge Matthew Kacsmaryk issued a preliminary ruling blocking the U.S. Food and Drug Administration’s approval of mifepristone for abortions, while a case questioning the safety of the drug proceeds in court. (A vast body of evidence indicates that mifepristone is safe.)

This ruling would knock out mifepristone access in abortion havens like New York and New Jersey, but Kacsmaryk delayed his decision from taking effect for seven days to give the Biden administration time to respond.

The Department of Justice, which represents the FDA, quickly filed its notice of appeal late Friday evening to the U.S. Court of Appeals for the Fifth Circuit. On Monday, the U.S. Department of Justice requested that the appeals court continue to delay the block on mifepristone and keep the pill available while the case is pending.

In the motion, the DOJ railed against Kacsmaryk’s ruling.

“Rather than preserving the status quo, as preliminary relief is meant to do, the district court upended decades of reliance by blocking FDA’s approval of mifepristone and depriving patients of access to this safe and effective treatment, based on the court’s own misguided assessment of the drug’s safety,” the motion stated.

Meanwhile, the DOJ is also trying to figure out how to reconcile Kacsmaryk’s decision with a conflicting ruling out of Washington state. In a separate case, Judge Thomas O. Rice of the Eastern District of Washington issued a preliminary injunction Friday to preserve access to mifepristone in 17 states and Washington D.C. The decision blocked the FDA from “altering the status quo and rights as it relates to the availability of mifepristone” under current regulations.

On Monday, the Department of Justice asked Rice for clarification on what to do if Kacsmaryk’s decision to suspend FDA approval for mifepristone is upheld. “To ensure that defendants comply with all court orders in these unusual circumstances, defendants respectfully request that this court clarify their obligations,” the DOJ wrote.

The ruling out of Washington only applies to states where attorneys general filed a lawsuit seeking to keep mifepristone available. New Jersey and New York are not among them – meaning the decision doesn’t grant them any protection from Kacsmaryk’s attempted ban.

New York Attorney General Letitia James’ office did not respond to a request for comment Monday on why she did not participate in the Washington lawsuit.

Julia Wiacek, a spokesperson for New Jersey Attorney General Matt Platkin, directed Gothamist to his statement on Twitter, which called Kacsmaryk’s ruling “misguided” but did not address the question about participating in the Washington lawsuit.

Some advocates are calling on Biden to simply defy Kacsmaryk’s ruling, regardless of what happens on appeal.

As of now, mifepristone is still available in New York and New Jersey. But even if it is banned, there will be other ways to get an abortion in legal states – including a procedure in a clinic and medication workarounds.

Tagged

abortion

new york state

Health and Science


Caroline Lewis

Caroline Lewis is on the health care beat for WNYC and Gothamist. She has covered COVID, a nurses' strike, the overdose crisis and New York’s marijuana legalization effort, and spent a year investigating patients' medical bills. She always wants to hear about how everyday New Yorkers experience the health system. Got a tip? Email [email protected].

Read more

Gothamist is funded by sponsors and member donations


Gothamist is funded by sponsors and member donations


MORE news

NY Archdiocese will soon settle $800M clergy sexual abuse claims

The deal would compensate over 1,300 alleged victims and help the church avoid bankruptcy.

By

Arya Sundaram

Published Oct 24, 2026 at 6:31 p.m. ET


Chinatown residents file lawsuit against after-hours construction on new 'mega jail'

Residents cite sleep disruption and dust-induced illness from nearly ‘round the clock’ construction.

By

Arya Sundaram

News

Chinatown residents file lawsuit against after-hours construction on new 'mega jail'

Residents cite sleep disruption and dust-induced illness from nearly ‘round the clock’ construction.

By

Arya Sundaram


Peepapalooza: NYC is heading to the Hudson Valley to watch the leaves

By

Elizabeth Shwe

and

Sean Carlson

NYPD: Officer shot, injured knife-wielding woman during ‘chaotic’ night at Queens home

By

Ryan Kost

3 slates vying to run Jersey City school board as city stares down major tax hikes

By

Michael Sol Warren


Never miss a story

Catch up on the most important headlines with a roundup of essential NYC stories, delivered to your inbox daily.

Sign upEmail address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .